PRPO – Precipio Inc
Precipio, Inc.PRPO
$14.26Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $23,095,212.00
EPSttm : -1.19
Precipio, Inc.
$14.26
1.66%$0.24Float Short %
0.67
Margin Of Safety %
-28
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
6.25
Price
14.25
Target Price
19
Analyst Recom
1
Performance Q
44.04
Relative Volume
0.4
Beta
1.09
Ticker: PRPO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | PRPO | 14.7 | N/A | N/A | 0 |
| 2025-07-28 | PRPO | 14.4 | N/A | N/A | 0 |
| 2025-07-29 | PRPO | 14.45 | N/A | N/A | 0 |
| 2025-07-30 | PRPO | 14.4884 | N/A | N/A | 0 |
| 2025-07-31 | PRPO | 14.26 | N/A | N/A | 0 |
| 2025-08-01 | PRPO | 14.46 | N/A | N/A | 0 |
| 2025-08-04 | PRPO | 14.2 | N/A | N/A | 0 |
| 2025-08-05 | PRPO | 14.21 | N/A | N/A | 0 |
| 2025-08-06 | PRPO | 14.58 | N/A | N/A | 0 |
| 2025-08-07 | PRPO | 14.2 | N/A | N/A | 0 |
| 2025-08-08 | PRPO | 13.9 | N/A | N/A | 0 |
| 2025-08-11 | PRPO | 13.8 | N/A | N/A | 0 |
| 2025-08-12 | PRPO | 14.08 | N/A | N/A | 0 |
| 2025-08-13 | PRPO | 14.24 | N/A | N/A | 0 |
| 2025-08-14 | PRPO | 14.7 | N/A | N/A | 0 |
| 2025-08-15 | PRPO | 14.7 | N/A | N/A | 0 |
| 2025-08-18 | PRPO | 14.18 | N/A | N/A | 0 |
| 2025-08-19 | PRPO | 14 | N/A | N/A | 0 |
| 2025-08-20 | PRPO | 14.54 | N/A | N/A | 0 |
| 2025-08-21 | PRPO | 14.5 | N/A | N/A | 0 |
| 2025-08-22 | PRPO | 14.3 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | PRPO | 14.70 | - | - | -6.25 |
| 2025-07-28 | PRPO | 14.76 | - | - | -6.25 |
| 2025-07-29 | PRPO | 14.45 | - | - | -6.25 |
| 2025-07-30 | PRPO | 14.48 | - | - | -6.25 |
| 2025-07-31 | PRPO | 14.26 | - | - | -6.25 |
| 2025-08-01 | PRPO | 14.46 | - | - | -6.25 |
| 2025-08-04 | PRPO | 14.51 | - | - | -6.25 |
| 2025-08-05 | PRPO | 14.65 | - | - | -6.25 |
| 2025-08-06 | PRPO | 14.07 | - | - | -6.25 |
| 2025-08-07 | PRPO | 14.20 | - | - | -6.25 |
| 2025-08-08 | PRPO | 13.90 | - | - | -6.25 |
| 2025-08-11 | PRPO | 13.90 | - | - | -6.25 |
| 2025-08-12 | PRPO | 13.98 | - | - | -6.25 |
| 2025-08-13 | PRPO | 14.29 | - | - | -6.25 |
| 2025-08-14 | PRPO | 14.58 | - | - | -6.25 |
| 2025-08-15 | PRPO | 14.69 | - | - | -6.25 |
| 2025-08-18 | PRPO | 14.11 | - | - | -6.25 |
| 2025-08-19 | PRPO | 14.30 | - | - | -6.25 |
| 2025-08-20 | PRPO | 14.40 | - | - | -6.25 |
| 2025-08-21 | PRPO | 14.59 | - | - | -6.25 |
| 2025-08-22 | PRPO | 14.25 | - | - | -6.25 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | PRPO | 6.96 | 48.29 | 1.19 |
| 2025-07-28 | PRPO | 6.96 | 49.77 | 1.19 |
| 2025-07-29 | PRPO | 6.88 | 49.77 | 1.19 |
| 2025-07-30 | PRPO | 6.89 | 49.77 | 1.19 |
| 2025-07-31 | PRPO | 6.89 | 49.77 | 1.19 |
| 2025-08-01 | PRPO | 6.89 | 49.77 | 1.19 |
| 2025-08-04 | PRPO | 6.89 | 52.54 | 1.19 |
| 2025-08-05 | PRPO | 6.89 | 52.54 | 1.19 |
| 2025-08-06 | PRPO | 6.89 | 52.54 | 1.19 |
| 2025-08-07 | PRPO | 6.89 | 52.54 | 1.19 |
| 2025-08-08 | PRPO | 6.88 | 52.54 | 1.19 |
| 2025-08-11 | PRPO | 6.88 | 58.14 | 1.19 |
| 2025-08-12 | PRPO | 6.88 | 58.14 | 0.71 |
| 2025-08-13 | PRPO | 6.88 | 58.14 | 0.71 |
| 2025-08-14 | PRPO | 6.89 | 58.14 | 0.71 |
| 2025-08-15 | PRPO | 6.88 | 58.14 | 0.71 |
| 2025-08-18 | PRPO | 6.40 | -8.32 | 0.67 |
| 2025-08-19 | PRPO | 6.40 | -8.32 | 0.67 |
| 2025-08-20 | PRPO | 6.32 | -8.32 | 0.67 |
| 2025-08-21 | PRPO | 6.40 | -8.32 | 0.67 |
| 2025-08-22 | PRPO | 6.40 | -8.32 | 0.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.93
Avg. EPS Est. Next Quarter
Insider Transactions
6.4
Institutional Transactions
-8.32
Beta
1.09
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
Fair Value
10.23
Quality Score
45
Growth Score
55
Sentiment Score
82
Actual DrawDown %
92.2
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.09
P/B
1.76
P/Free Cash Flow
41.23
EPS
-1.21
Average EPS Est. Cur. Y
-6.25
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8.48
Relative Volume
0.4
Return on Equity vs Sector %
-39.3
Return on Equity vs Industry %
-25.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading